S Died in Health Policy
Email me when SB 1554 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 1554. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would make the health information and proprietary pricing details in the Department of Health’s annual report on experimental treatments for terminal or rare diseases confidential and not subject to public‑records requests. It is intended to protect patients’ sensitive medical data and commercial pricing information. The measure did not pass and died in the Health Policy committee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 1554
3 free questions a day, no accountHistory
- Died in Health Policy
- Introduced
- Referred to Health Policy; Appropriations Committee on Health and Human Services; Appropriations
- Filed
Sponsors
- Danny Burgess (R) · sponsor
- Burgess
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 1554 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 1554 freeOr ask your AI assistant about SB 1554 directly:
Add to Claude, ChatGPT or Cursor